INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia. Murthy V, Hanson E, DeMartinis N, Asgharnejad M, et al. Schizophr Res 2024;270:249-257.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Murthy V, Hanson E, DeMartinis N, Asgharnejad M, et al. INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia. Schizophr Res 2024;270:249-257.
PMID: 38943928